Global Hyaluronic Acid-based Biomaterials 麻豆原创 Growth 2025-2031

Publication ID:

LPI03255422

Publication Date:

March 25, 2025

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Hyaluronic Acid-based Biomaterials market size is predicted to grow from US$ 231 million in 2025 to US$ 278 million in 2031; it is expected to grow at a CAGR of 3.1% from 2025 to 2031.
Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.
Common commercially available hyaluronic acid-based biomaterials are mainly hyaluronic acid. Hyaluronic acid (HA) is known as hyaluronan or hyaluronate. In this report, the volume of hyaluronic acid-based biomaterials is calculated by pure hyaluronic acid powder.
The major manufacturers of Hyaluronic Acid-based Biomaterials are concentrated in Bloomage BioTechnology, Shandong Galaxy Bio-Tech, Kewpie, CPN, China Eastar and FocusChem Biotech. Bloomage BioTechnology is the world leader, holding 42% production market share.
In the consumption market, China is the largest consumption market. The consumption share of China is 27%.
The 鈥淗yaluronic Acid-based Biomaterials Industry Forecast鈥� looks at past sales and reviews total world Hyaluronic Acid-based Biomaterials sales in 2024, providing a comprehensive analysis by region and market sector of projected Hyaluronic Acid-based Biomaterials sales for 2025 through 2031. With Hyaluronic Acid-based Biomaterials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyaluronic Acid-based Biomaterials industry.
This Insight Report provides a comprehensive analysis of the global Hyaluronic Acid-based Biomaterials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyaluronic Acid-based Biomaterials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Hyaluronic Acid-based Biomaterials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyaluronic Acid-based Biomaterials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyaluronic Acid-based Biomaterials.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyaluronic Acid-based Biomaterials market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cosmetic Grade
Food Grade
Pharmaceutical Grade
Segmentation by Application:
Medical Hygiene
Plastic Surgery
Health Products
Cosmetic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kewpie
CPN
Shiseido
Novozymes
Bloomage BioTechnology
Shandong Galaxy Bio-Tech
China Eastar
FocusChem Biotech
Shandong Topscience Biotech
QuFu GuangLong Biochem
Weifang Lide Bioengineering
Jiangsu Haihua Biotech
Qufu Liyang Biochem Industrial
Tongxiang Hengji biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hyaluronic Acid-based Biomaterials market?
What factors are driving Hyaluronic Acid-based Biomaterials market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hyaluronic Acid-based Biomaterials market opportunities vary by end market size?
How does Hyaluronic Acid-based Biomaterials break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Hyaluronic Acid-based Biomaterials Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hyaluronic Acid-based Biomaterials by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hyaluronic Acid-based Biomaterials by Country/Region, 2020, 2024 & 2031
2.2 Hyaluronic Acid-based Biomaterials Segment by Type
2.2.1 Cosmetic Grade
2.2.2 Food Grade
2.2.3 Pharmaceutical Grade
2.3 Hyaluronic Acid-based Biomaterials Sales by Type
2.3.1 Global Hyaluronic Acid-based Biomaterials Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Hyaluronic Acid-based Biomaterials Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Hyaluronic Acid-based Biomaterials Sale Price by Type (2020-2025)
2.4 Hyaluronic Acid-based Biomaterials Segment by Application
2.4.1 Medical Hygiene
2.4.2 Plastic Surgery
2.4.3 Health Products
2.4.4 Cosmetic
2.5 Hyaluronic Acid-based Biomaterials Sales by Application
2.5.1 Global Hyaluronic Acid-based Biomaterials Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Hyaluronic Acid-based Biomaterials Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Hyaluronic Acid-based Biomaterials Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Hyaluronic Acid-based Biomaterials Breakdown Data by Company
3.1.1 Global Hyaluronic Acid-based Biomaterials Annual Sales by Company (2020-2025)
3.1.2 Global Hyaluronic Acid-based Biomaterials Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Hyaluronic Acid-based Biomaterials Annual Revenue by Company (2020-2025)
3.2.1 Global Hyaluronic Acid-based Biomaterials Revenue by Company (2020-2025)
3.2.2 Global Hyaluronic Acid-based Biomaterials Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Hyaluronic Acid-based Biomaterials Sale Price by Company
3.4 Key Manufacturers Hyaluronic Acid-based Biomaterials Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyaluronic Acid-based Biomaterials Product Location Distribution
3.4.2 Players Hyaluronic Acid-based Biomaterials Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Hyaluronic Acid-based Biomaterials by Geographic Region
4.1 World Historic Hyaluronic Acid-based Biomaterials 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Hyaluronic Acid-based Biomaterials Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hyaluronic Acid-based Biomaterials Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hyaluronic Acid-based Biomaterials 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Hyaluronic Acid-based Biomaterials Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hyaluronic Acid-based Biomaterials Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hyaluronic Acid-based Biomaterials Sales Growth
4.4 APAC Hyaluronic Acid-based Biomaterials Sales Growth
4.5 Europe Hyaluronic Acid-based Biomaterials Sales Growth
4.6 Middle East & Africa Hyaluronic Acid-based Biomaterials Sales Growth
5 Americas
5.1 Americas Hyaluronic Acid-based Biomaterials Sales by Country
5.1.1 Americas Hyaluronic Acid-based Biomaterials Sales by Country (2020-2025)
5.1.2 Americas Hyaluronic Acid-based Biomaterials Revenue by Country (2020-2025)
5.2 Americas Hyaluronic Acid-based Biomaterials Sales by Type (2020-2025)
5.3 Americas Hyaluronic Acid-based Biomaterials Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyaluronic Acid-based Biomaterials Sales by Region
6.1.1 APAC Hyaluronic Acid-based Biomaterials Sales by Region (2020-2025)
6.1.2 APAC Hyaluronic Acid-based Biomaterials Revenue by Region (2020-2025)
6.2 APAC Hyaluronic Acid-based Biomaterials Sales by Type (2020-2025)
6.3 APAC Hyaluronic Acid-based Biomaterials Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hyaluronic Acid-based Biomaterials by Country
7.1.1 Europe Hyaluronic Acid-based Biomaterials Sales by Country (2020-2025)
7.1.2 Europe Hyaluronic Acid-based Biomaterials Revenue by Country (2020-2025)
7.2 Europe Hyaluronic Acid-based Biomaterials Sales by Type (2020-2025)
7.3 Europe Hyaluronic Acid-based Biomaterials Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hyaluronic Acid-based Biomaterials by Country
8.1.1 Middle East & Africa Hyaluronic Acid-based Biomaterials Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hyaluronic Acid-based Biomaterials Revenue by Country (2020-2025)
8.2 Middle East & Africa Hyaluronic Acid-based Biomaterials Sales by Type (2020-2025)
8.3 Middle East & Africa Hyaluronic Acid-based Biomaterials Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyaluronic Acid-based Biomaterials
10.3 Manufacturing Process Analysis of Hyaluronic Acid-based Biomaterials
10.4 Industry Chain Structure of Hyaluronic Acid-based Biomaterials
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyaluronic Acid-based Biomaterials Distributors
11.3 Hyaluronic Acid-based Biomaterials Customer
12 World Forecast Review for Hyaluronic Acid-based Biomaterials by Geographic Region
12.1 Global Hyaluronic Acid-based Biomaterials 麻豆原创 Size Forecast by Region
12.1.1 Global Hyaluronic Acid-based Biomaterials Forecast by Region (2026-2031)
12.1.2 Global Hyaluronic Acid-based Biomaterials Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hyaluronic Acid-based Biomaterials Forecast by Type (2026-2031)
12.7 Global Hyaluronic Acid-based Biomaterials Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Kewpie
13.1.1 Kewpie Company Information
13.1.2 Kewpie Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.1.3 Kewpie Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Kewpie Main Business Overview
13.1.5 Kewpie Latest Developments
13.2 CPN
13.2.1 CPN Company Information
13.2.2 CPN Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.2.3 CPN Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CPN Main Business Overview
13.2.5 CPN Latest Developments
13.3 Shiseido
13.3.1 Shiseido Company Information
13.3.2 Shiseido Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.3.3 Shiseido Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shiseido Main Business Overview
13.3.5 Shiseido Latest Developments
13.4 Novozymes
13.4.1 Novozymes Company Information
13.4.2 Novozymes Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.4.3 Novozymes Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novozymes Main Business Overview
13.4.5 Novozymes Latest Developments
13.5 Bloomage BioTechnology
13.5.1 Bloomage BioTechnology Company Information
13.5.2 Bloomage BioTechnology Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.5.3 Bloomage BioTechnology Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bloomage BioTechnology Main Business Overview
13.5.5 Bloomage BioTechnology Latest Developments
13.6 Shandong Galaxy Bio-Tech
13.6.1 Shandong Galaxy Bio-Tech Company Information
13.6.2 Shandong Galaxy Bio-Tech Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.6.3 Shandong Galaxy Bio-Tech Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shandong Galaxy Bio-Tech Main Business Overview
13.6.5 Shandong Galaxy Bio-Tech Latest Developments
13.7 China Eastar
13.7.1 China Eastar Company Information
13.7.2 China Eastar Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.7.3 China Eastar Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 China Eastar Main Business Overview
13.7.5 China Eastar Latest Developments
13.8 FocusChem Biotech
13.8.1 FocusChem Biotech Company Information
13.8.2 FocusChem Biotech Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.8.3 FocusChem Biotech Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 FocusChem Biotech Main Business Overview
13.8.5 FocusChem Biotech Latest Developments
13.9 Shandong Topscience Biotech
13.9.1 Shandong Topscience Biotech Company Information
13.9.2 Shandong Topscience Biotech Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.9.3 Shandong Topscience Biotech Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shandong Topscience Biotech Main Business Overview
13.9.5 Shandong Topscience Biotech Latest Developments
13.10 QuFu GuangLong Biochem
13.10.1 QuFu GuangLong Biochem Company Information
13.10.2 QuFu GuangLong Biochem Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.10.3 QuFu GuangLong Biochem Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 QuFu GuangLong Biochem Main Business Overview
13.10.5 QuFu GuangLong Biochem Latest Developments
13.11 Weifang Lide Bioengineering
13.11.1 Weifang Lide Bioengineering Company Information
13.11.2 Weifang Lide Bioengineering Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.11.3 Weifang Lide Bioengineering Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Weifang Lide Bioengineering Main Business Overview
13.11.5 Weifang Lide Bioengineering Latest Developments
13.12 Jiangsu Haihua Biotech
13.12.1 Jiangsu Haihua Biotech Company Information
13.12.2 Jiangsu Haihua Biotech Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.12.3 Jiangsu Haihua Biotech Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jiangsu Haihua Biotech Main Business Overview
13.12.5 Jiangsu Haihua Biotech Latest Developments
13.13 Qufu Liyang Biochem Industrial
13.13.1 Qufu Liyang Biochem Industrial Company Information
13.13.2 Qufu Liyang Biochem Industrial Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.13.3 Qufu Liyang Biochem Industrial Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Qufu Liyang Biochem Industrial Main Business Overview
13.13.5 Qufu Liyang Biochem Industrial Latest Developments
13.14 Tongxiang Hengji biotechnology
13.14.1 Tongxiang Hengji biotechnology Company Information
13.14.2 Tongxiang Hengji biotechnology Hyaluronic Acid-based Biomaterials Product Portfolios and Specifications
13.14.3 Tongxiang Hengji biotechnology Hyaluronic Acid-based Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Tongxiang Hengji biotechnology Main Business Overview
13.14.5 Tongxiang Hengji biotechnology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.